Approval · Notice of Compliance 22471 · 2019
INHIBACE: Notice of Compliance 22471
Issued July 29, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22471
- Date
- July 29, 2019
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Labelling update. change in product ownership
Products in this notice
Medicinal ingredients
- CILAZAPRIL MONOHYDRATE 2.5 MG per TAB
- CILAZAPRIL MONOHYDRATE 5 MG per TAB